Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
By Amina Niasse NEW YORK, June 2 (Reuters) - Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee health plan effective July 1, according to materials viewed by Reuters on Tuesday
They reflect normal bacterial fermentation in your digestive tract, accelerated by slower gastric emptying
Watching their condition becomes very important
The distinction matters clinically
US$ 21.65
US$ 27.46
US$ 29.47
US$ 26.82
US$ 20.58
US$ 26.95
